Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity
- 28 June 2001
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 20 (29), 3806-3813
- https://doi.org/10.1038/sj.onc.1204487
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 42 references indexed in Scilit:
- Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53Oncogene, 2001
- Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibitionLeukemia, 2000
- Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive ApoptosisNeoplasia, 2000
- Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugsJCI Insight, 2000
- Molecular effects of paclitaxel: Myths and reality (a critical review)International Journal of Cancer, 1999
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJCI Insight, 1999
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell lineOncogene, 1997
- Loss of function and p53 protein stabilizationOncogene, 1997
- A p53-Dependent Mouse Spindle CheckpointScience, 1995